Impax Laboratories Inc. (IPXL) Tops Q1 EPS by 3c

Impax Laboratories Inc. (NASDAQ: IPXL) reported Q1 EPS of $0.52, $0.03 better than the analyst estimate of $0.49. Revenue for the quarter came in at $123.3 million versus the consensus estimate of $163.74 million.

For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
• Morgan Stanley Upgrades Oil India Ltd. (OINL:IN) to Equalweight